文献速递角膜与眼表疾病

非诺贝特抑制苯扎氯铵诱导的眼表鳞状化生

PPAR-α Agonist Fenofibrate Suppressed the Formation of Ocular Surface Squamous Metaplasia Induced by Topical Benzalkonium Chloride.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

该研究在小鼠模型中用局部苯扎氯铵诱导眼表鳞状化生,并分组给予非诺贝特或联合MK886干预。结果显示局部非诺贝特可抑制泪膜不稳定、减少K10和Ki67表达、维持杯状细胞数量、降低角膜F4/80阳性细胞及TNF-α和IL-6 mRNA水平,且这些效应可被MK886减弱。

要点

  • 局部非诺贝特抑制BAC诱导的眼表鳞状化生形成。
  • 非诺贝特减少角膜K10和Ki67表达并维持杯状细胞数量。
  • 非诺贝特降低角膜F4/80阳性细胞及TNF-α和IL-6 mRNA水平。

核心结论

  • 局部应用非诺贝特可抑制眼表鳞状化生的形成,可能通过PPAR-α信号通路介导。

研究设计与样本

  • 小鼠模型通过局部BAC应用16天诱导眼表鳞状化生,分为BAC+UT、BAC+Vehicle、BAC+Feno和BAC+Feno+MK886四组。

主要发现

  • BAC+Feno组K10和Ki67表达低于其他三组。
  • BAC+UT和BAC+Vehicle组杯状细胞减少,而BAC+Feno组杯状细胞得以维持。
  • BAC+Feno组角膜F4/80阳性细胞数及TNF-α和IL-6 mRNA水平显著降低。
  • 非诺贝特的上述效应可被MK886减弱。
  • 非诺贝特以剂量依赖方式显著抑制RAW264.7细胞活力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the effects and mechanisms of the peroxisome proliferator-activated receptor alpha (PPAR-α) agonist fenofibrate on the formation of ocular surface squamous metaplasia induced by topical benzalkonium chloride (BAC) in a mouse model. METHODS: Ocular surface squamous metaplasia was induced in 16 days by topical BAC application in mice. During the period of induction, mice were divided into four groups: no additional treatment (BAC+UT), topical vehicle (BAC+Vehicle), topical fenofibrate (BAC+Feno), or topical fenofibrate plus intraperitoneal injection of MK886 (BAC+Feno+MK886). The parameters of tear film were evaluated on day 16, and eye specimens were collected. Histologic investigation; PAS assays; immunostaining for cytokeratin 10 (K10), Ki67, and F4/80; and PCR assays for TNF-α and IL-6 were performed. Cell Counting Kit 8 (CCK-8) assays were performed to evaluate the inhibitory effects of fenofibrate on RAW264.7 cells. RESULTS: Fenofibrate suppressed the formation of BAC-induced instable tear film. In the BAC+Feno group, the expression of K10 and Ki67 was lower than in the other three groups. The number of goblet cells was reduced in eyes of the BAC+UT and BAC+Vehicle groups but was maintained in eyes of the BAC+Feno group. The number of F4/80-positive cells and the levels of TNF-α and IL-6 mRNA were significantly reduced in the cornea of the BAC+Feno group. These effects of fenofibrate could be attenuated by MK886. The cell viability of RAW264.7 cells could be significantly inhibited by fenofibrate in a dose-dependent pattern. CONCLUSIONS: Topical application of fenofibrate suppressed the formation of ocular surface squamous metaplasia, which might be mediated through the PPAR-α signaling pathway.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. He H, Liang M, Li L, et al. PPAR-α Agonist Fenofibrate Suppressed the Formation of Ocular Surface Squamous Metaplasia Induced by Topical Benzalkonium Chloride. Invest Ophthalmol Vis Sci. 2020. PMID: 32232349. doi:10.1167/iovs.61.3.54

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。